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Abstract 26 
The aim of this study was to investigate comprehensively the metabolic 27 
pathways and human bioavailability of anthocyanins and other phenolic 28 
compounds in apple matrix, and to elucidate potential intake biomarkers. After 29 
the acute intake of a red-fleshed apple snack, plasma and urine were collected 30 
and analyzed by UPLC-MS/MS. A total of 37 phase-II and microbial phenolic 31 
metabolites were detected in plasma and urine. Among these, phloretin 32 
glucuronide, cyanidin-3-O-galactoside (plasma and urine) and peonidin-3-O-33 
galactoside (urine) were the only metabolites detected in all the volunteers and 34 
not detected at basal conditions. The maximum urine excretion was detected at 35 
2-4 h, and the main increase in plasma of phloretin glucuronide and cyanidin-3-36 
O-galactoside was observed at 2h post-intake (61.0  6.82 and 10.3  1.50 nM, 37 
respectively). These metabolites could be selected as the best intake 38 
biomarkers of red-fleshed apple that might be useful in human intervention 39 
studies when studying the bioactivity of red-fleshed apple. 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
Keywords: anthocyanins, metabolic pathways, phenolic compounds, red-49 
fleshed apple, UPLC-MS/MS. 50 
51 
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1. INTRODUCTION 52 
Apples are one of the most commonly consumed fruits and their diverse and 53 
high (poly)phenol content is considered one of the most important determinants 54 
of their health-promoting properties (Hyson, 2011; Bondonno et al., 2018).  55 
In the last few years, there has been a rapidly increasing interest in potential 56 
crops for coloring food naturally without transgenic or cysgenic programs. In 57 
order to obtain better-quality apples with added healthy properties, new 58 
genotypes of apple with red-flesh have been obtained by innovative breeding 59 
strategies through cross-breeding programs with wild red-fleshed apple 60 
varieties (with poor taste) and commercial good-flavored white-fleshed apples 61 
(Deacon, www.suttonelms.org.uk). The resulting red-fleshed apples contain a 62 
high amount of anthocyanin compounds in their flesh and have a good-tasting. 63 
Apart from anthocyanins, red-fleshed apples are also a rich source of other 64 
(poly)phenols that are also detected in common apple varieties such as 65 
phenolic acids, dihydrochalcones, flavan-3-ols, and flavonols (Bars-Cortina et 66 
al. 2017). Due to the enhanced content of anthocyanins reported in these red-67 
fleshed apples, different studies have shown that the total phenolic content and 68 
antioxidant capacity were significantly higher in red-fleshed apples compared to 69 
traditional white-fleshed apples, which indicates that these apples could have 70 
presumably added healthy properties (Rupasinghe et al., 2010; Bars-Cortina et 71 
al. 2017).   72 
Regarding the bioavailability of apple phenolic compounds, only a few 73 
studies have investigated the metabolism of these compounds in common 74 
varieties of apple and most of them were focused on the bioavailability after 75 
apple juice (Kahle et al.; 2011; Trošt et al. 2018) or apple cider consumption 76 
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 4 
(DuPont et al., 2002; Marks et al., 2009), with only one study reporting the 77 
phenolic metabolites after consumption of apple fruit (Saenger et al., 2017). 78 
Concerning the bioavailability of anthocyanins, there are plenty of studies 79 
reporting their human bioavailability and metabolism, however, they have been 80 
only studied in other food matrices such as blueberries, elderberries, 81 
blackcurrants, strawberries and red grapes or red wine (Wu et al., 2002; Bitsch 82 
et al., 2004; Stalmach et al., 2012; Kuntz et al., 2015; Zhong et al., 2017). So, to 83 
our knowledge, no study has been reported in the literature regarding the 84 
bioavailability of common apple phenolic compounds together with 85 
anthocyanidins in the same food matrix, which represents a specific 86 
characteristic of red-fleshed apple varieties.  87 
In the case of anthocyanins, various types of food samples have been used 88 
to determine the effects of food matrix on their bioavailability. For instance, 89 
anthocyanins in strawberries, blood oranges and red wine have been reported 90 
to be highly bioavailable with their urinary levels varying between 1-5% of the 91 
ingested dose (Wallace et al., 2016). The differences reported in anthocyanin 92 
bioavailability from different food sources, to a large extent, is due to the 93 
presence of several structurally diverse anthocyanins in these foods, and the 94 
interactions between food matrix and these specific anthocyanins. Therefore, 95 
human postprandial studies are very useful and can contribute to knowledge 96 
about the food matrix affecting polyphenol bioavailability (Motilva et al. 2015). 97 
Moreover, the measurement of dietary exposure and reliable intake 98 
biomarkers before investigating the potential health benefits of a new food 99 
product is of crucial importance for the discovery of unbiased associations 100 
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between the intake of bioactive compounds and the observed effects (Dragsted 101 
et al. 2018). 102 
So, considering the scarce data regarding the human bioavailability and 103 
metabolism of apple phenolic compounds, in the present work we aimed to 104 
investigate the bioavailability and the complex metabolic pathways of the red-105 
fleshed apple as an innovative food source rich in different polyphenols, 106 
including anthocyanins. Among all the identified metabolites, we also aimed to 107 
identify and select those plasmatic and urinary metabolites that could be 108 
considered as potential intake biomarkers of red-fleshed apple consumption 109 
and might be used to establish the relationship between their intake and health 110 
benefits in future human intervention studies. 111 
 112 
2. MATERIALS AND METHODS 113 
2.1. Chemicals and reagents 114 
Cyanidin-3-O-galactoside, eriodictyol, quercetin-3-O-glucoside, quercetin-3-115 
O-rhamnoside, dimer B2, phloretin-2’-O-glucoside, p-coumaric acid, and caffeic 116 
acid were purchased from Extrasynthese (Genay, France). p-Hydroxybenzoic 117 
acid, 3,4-dihydroxybenzoic acid (aka protocatechuic acid), hippuric acid, 3-(4’-118 
hydroxyphenyl)acetic acid, 3-(3’,4’-dihydroxyphenyl)acetic acid, 3-(3’-119 
hydroxyphenyl)propionic acid, 3-(3’,4’-dihydroxyphenyl)propionic acid (aka 120 
dihydrocaffeic acid), 3-(3’-hydroxy-4’-methoxyphenyl)propionic acid (aka 121 
dihydroferulic acid), epicatechin, and chlorogenic acid were from Sigma-Aldrich 122 
(St. Louis, MO, USA). Vanillic acid and ferulic acid were from Fluka (Buchs, 123 
Switzerland).  Vanillic acid-4-O-sulphate, catechol-4-O-sulphate, and 4-methyl 124 
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catechol sulphate were synthesized according to Pimpao et al. (2015) and were 125 
kindly supplied by Dr. Claudia N. Santos (Portugal). 126 
Methanol (HPLC grade), acetonitrile (HPLC grade), and acetic acid were 127 
purchased from Scharlab Chemie (Sentmenat, Catalonia, Spain). The water 128 
used was Milli-Q quality (Millipore Corp, Bedford, MA, USA).  129 
Stock solutions of standard compounds were prepared by dissolving each 130 
compound in methanol at a concentration of 1000 mg/L, and stored in a dark 131 
flask at −30 ºC. 132 
 133 
2.2. Apple snack 134 
The red-fleshed ‘Redlove’ apple variety was provided by NUFRI SAT 135 
(Mollerussa, Lleida, Spain), and planted in “La Rasa” experimental plot (La 136 
Rasa, Soria, Spain). To increase the useful life, obtaining good shelf-stability 137 
and, at the same time, minimize changes in the bioactive compounds of red-138 
fleshed apples, the freeze-dried snack format was selected. Before drying, the 139 
apples were washed, and dried. Then, the apple core was removed and the 140 
whole apple (with peel) was cut into 1 cm-sized cubes. The apple cubes were 141 
frozen in liquid nitrogen and lyophilization was then performed with a first drying 142 
at 0.6 bar with a temperature ramp of −20 to 0 °C for 25 hours, followed by a 143 
second complete vacuum drying with a temperature ramp of 0 to 20 °C for 40 144 
hours (Lyophilizer TELSTAR Lyobeta 15, Terrassa, Spain). The freeze-dried 145 
apple cubes were immediately transferred to airtight plastic containers and 146 
refrigerated (2 ºC) until the analysis of their phenolic composition and use in the 147 
acute intake study. A photograph of the red-fleshed apple snack is shown in 148 
Graphical Abstract. 149 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 7 
The analysis of the phenolic composition of the apple snack was based on 150 
the previous study by Bars-Cortina et al. (2017). Prior to the chromatographic 151 
analysis of the apple (poly)phenols, a fine powder of the freeze-dried samples 152 
was obtained with the aid of an analytical mill (A11, IKA, Germany). The 153 
ingested portion of the apple snack contained a total of 196 mg of phenolic 154 
compounds. The nutritional composition and the detailed phenolic composition 155 
of the red-fleshed apple snack are presented in the Supporting Material in 156 
Table S1 and Table S2, respectively. 157 
 158 
2.3. Human intervention study and biological sample collection 159 
The protocol of the study was approved by the Ethical Committee of the 160 
Human Clinical Research Unit at the Arnau Vilanova University Hospital, Lleida, 161 
Spain (Approval Number: 13/2016). Ten healthy participants (five females and 162 
five males, mean age 37.3 ± 8.4 years) with a body mass index (BMI) of 18.5–163 
24.9 kg/m2 were enrolled. Exclusion criteria were pregnancy or lactation, any 164 
chronic medication, any antibiotic treatment during the 4 months prior to the 165 
study, cigarette smoking, alcohol intake > 80 g/day and use of dietary 166 
supplements. After two days of a diet low in phenolic compounds, the 167 
participants were invited to eat a portion of 80 g of red-fleshed apple snack after 168 
fasting overnight. Human blood samples were obtained by venipuncture before 169 
(0 h) and after the apple snack intake at 0.5, 1, 2, 4, 6, and 24 h using 6 mL 170 
Vacutainer™ tubes (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) 171 
containing ethylenediamintetra acetic acid (EDTA) as an anticoagulant. To 172 
obtain the plasma samples, the blood tubes were centrifuged at 8784 g for 15 173 
min (Hettich, Tuttlingen, Germany). Aliquots were stored at −80 ºC until the 174 
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 8 
chromatographic analysis. On the other hand, urine samples were collected 12 175 
h before and at the interval times of 0-2, 2-4, 4-8, and 8-24 h after the apple 176 
snack intake. The total volume of each sample was measured before storing the 177 
aliquots at −80 ºC until the chromatographic analysis. 178 
 179 
2.3.1. Plasma samples  180 
Before the chromatographic analyses, the plasma samples were pre-treated 181 
by micro-Elution solid-phase extraction (µSPE) using OASIS HLB (2 mg, 182 
Waters, Milford, MA) micro-cartridges. The methodology used is the one 183 
reported in a previous study (Martí et al., 2010), but with some modifications. 184 
Briefly, the micro-cartridges were conditioned sequentially with 250 µL of 185 
methanol and 250 µL of 0.2% acetic acid. 350 µL of 4% phosphoric acid was 186 
added to 350 µL of the plasma sample, and then this solution was loaded into 187 
the micro-cartridges. The loaded micro-cartridges were cleaned up with 200 µL 188 
of Milli-Q water and 200 µL of 0.2% acetic acid. Then, the retained phenolic 189 
compounds were eluted with 2 x 50 µL of methanol. Each sample was prepared 190 
in triplicate. 191 
 192 
2.3.2. Urine samples  193 
The urine samples were also pre-treated by µSPE. The micro-cartridges and 194 
their conditioning and equilibration steps were the same as reported for plasma 195 
samples. In this case, 100 µL of phosphoric acid at 4% was added to 100 µL of 196 
the urine sample, and this solution was loaded into the micro-cartridge. The 197 
retained phenolic compounds were then eluted with 2 x 50 µL of methanol. 198 
Each sample was prepared in triplicate. 199 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 9 
2.4. Ultra-performance liquid chromatography coupled to tandem mass 200 
spectrometry (UPLC-MS/MS) 201 
LC analyses were carried out on an AcQuity Ultra-PerformanceTM liquid 202 
chromatography and tandem mass spectrometry equipment from Waters 203 
(Milford, MA, USA). Two chromatographic methods were used for the analysis 204 
of 1) anthocyanins and their metabolites, and 2) the rest of the phenolic 205 
compounds and their metabolites. In both methods, the flow rate was 0.3 206 
mL/min and the injection volume 2.5 μL. The UPLC.MS/MS conditions were the 207 
same used in our previous studies (Martí et al. 2010; Bars-Cortina et al. 2017; 208 
Yuste et al. 2018). Tandem MS analyses were carried out on a triple 209 
quadrupole detector (TQD) mass spectrometer (Waters, Milford, MA, USA) 210 
equipped with a Z-spray electrospray interface. The selected reaction 211 
monitoring (SRM) transition for quantification and the cone voltage and collision 212 
energy for the analysis of the phenolic metabolites are shown in Table 1.  213 
Due to the lack of commercial standards of phenolic metabolites, some of 214 
these compounds were tentatively quantified by using the calibration curve of 215 
their precursor or another phenolic compound with a similar structure. Methyl 216 
catechol glucuronide was tentatively quantified by using the calibration curve of 217 
4-methyl catechol sulphate. For hydroxybenzoic acid sulphate, the calibration 218 
curve of p-hydroxybenzoic acid was used; hydroxyhippuric acid with hippuric 219 
acid; protocatechuic acid sulphate with protocatechuic acid; vanillic acid 220 
glucuronide with vanillic acid; hydroxyphenylacetic acid sulphate and 221 
hydroxyphenylacetic acid glucuronide with 3-(4’-hydroxyphenyl)acetic acid; 222 
dihydroxyphenylacetic acid sulphate and dihydroxyphenylacetic acid 223 
glucuronide with 3-(3’,4’-dihydroxyphenyl)acetic acid; hydroxyphenylpropionic 224 
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acid sulphate and hydroxyphenylpropionic acid glucuronide with 3-(3’-225 
hydroxyphenyl)propionic acid; dihydroxyphenylpropionic acid sulphate with 3-226 
(3’,4’-hydroxyphenyl)propionic acid; hydroxymethoxyphenyl propionic acid 227 
sulphate (dihydroferulic acid sulphate) with 3-(3’-hydroxy-4’-228 
methoxyphenyl)propionic acid (dihydroferulic acid); coumaric acid sulphate with 229 
p-coumaric acid; caffeic acid sulphate with caffeic acid; ferulic acid sulphate 230 
with ferulic acid; hydroxyphenyl--valerolactone sulphate, dihydroxyphenyl--231 
valerolactone, dihydroxyphenyl--valerolactone glucuronide, dihydroxyphenyl--232 
valerolactone sulphate glucuronide, epicatechin sulphate, epicatechin 233 
glucuronide, and methyl epicatechin glucuronide with epicatechin; phloretin 234 
sulphate, phloretin glucuronide and phloretin sulphate glucuronide with 235 
phloretin-2’-O-glucoside; cyanidin arabinoside and peonidin-3-O-galactoside 236 
with cyanidin-3-O-galactoside. 237 
 238 
2.5. Statistical analysis 239 
The results are presented as mean values ± standard deviation (SD) for 240 
(poly)phenols in red-fleshed apple snacks, and as mean values ± standard error 241 
of the mean (SEM) for metabolites in the urine and plasma samples. For the 8 242 
metabolite groups (catechol/pyrogallol derivatives, benzoic acid derivatives, 243 
phenylacetic/phenylpropionic acid derivatives, phenyl--valerolactone 244 
derivatives, flavan-3-ol derivatives, phloretin derivatives, and anthocyanin 245 
derivatives), one-way repeated measures analysis of variance (ANOVA) was 246 
performed on the urine samples to compare the mean differences at the five 247 
defined time points. Post hoc analysis was conducted using pairwise 248 
comparisons with Bonferroni correction. Differences were considered significant 249 
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at p < 0.05. All statistical analyses were performed using the SPSS v 22.0 250 
software package.  251 
 252 
3. RESULTS AND DISCUSSION 253 
3.1. Red-fleshed apple snack phenolics characterization 254 
The total amount of phenolic compounds in the apple snack portion (80 g) 255 
administered to the volunteers accounted for 196 ± 10.7 mg and the analysis of 256 
the phenolic composition showed a wide range of phenolic groups (Table S2 257 
Supporting Material). The more abundant phenolic compounds were phenolic 258 
acids (45%), mainly chlorogenic acid; flavan-3-ols (7%), mainly epicatechin and 259 
its dimer; the flavonols (9%), mainly quercetin derivatives, and 260 
dihydrochalcones (17%), with phloretin glucoside being the main representative 261 
and a unique compound characteristic for apples. 262 
  Different from common apple species, red-fleshed apples, have an added 263 
value as they also contain around 22% of anthocyanins. Anthocyanins in red-264 
fleshed apple are located both in the peel and flesh (Bars-Cortina, et al., 2017), 265 
and are mainly represented by cyanidin-3-O-galactoside. This specific 266 
anthocyanin has only been detected in considerable amounts in chokeberry 267 
(Aronia melanocarpa) and lingonberry (Vaccinium vitis-idaea) (Zheng et al. 268 
2003), both fruits that usually do not form part of a regular diet. Therefore, 269 
cyanidin-3-O-galactoside could be considered a very characteristic compound 270 
from red-fleshed apple and white-flesh red-skin apples. 271 
Regarding the administered dose, anthocyanins have demonstrated 272 
beneficial effects at variable administered doses (7.35-640 mg/day) (Wallace, et 273 
al. 2016). Considering this range described in the literature as effective in the 274 
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prevention of chronic diseases, in the present study we selected a dose of 275 
anthocyanins around 50 mg/day (Table S2 Supporting Material) administered 276 
through a feasible amount of apple snack (80 g/day) that could be consumed 277 
daily by the volunteers without difficulty.  278 
 279 
3.2. Identification of the biological apple phenol metabolites by UPLC-280 
MS/MS 281 
In order to identify the phenolic metabolites generated after the acute intake 282 
of the red-fleshed apple snack, the detector system tandem MS was used due 283 
to its specificity, sensitivity and selectivity. The generated metabolites were 284 
determined and identified by the full scan mode in the MS mode, and in the 285 
daughter scan and SRM modes in the tandem MS mode. In addition to the 286 
detector system (MS/MS), authentic standards were also used when they were 287 
available to determine their retention time and identify the phenolic metabolites 288 
generated in plasma and urine samples. Their MS spectrum is shown in Figure 289 
S1 in Supporting Material).  290 
Although the volunteers spent two days on a diet low in phenolic compounds 291 
prior to the intervention day, some phenolic acids (phenylpropionic, 292 
phenylacetic, benzoic, and hydroxycinnamic acids) were detected and 293 
quantified in the analysis of the basal plasma and urine (fasting conditions) 294 
collected just before the apple snack intake (see Table S3 and S4 in 295 
Supporting Material). After subtraction of these basal levels of phenolics, a 296 
total of 37 phenolic metabolites were detected in the urine and/or plasma 297 
samples in increased amounts after the red-fleshed apple snack intake (Table 298 
1, and Tables S3 and S4 in Supporting Material). These metabolites included 299 
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four catechol and pyrogallol derivatives, six benzoic acid derivatives, five 300 
phenylacetic acid derivatives, six phenylpropionic acid derivatives, and four 301 
hydroxycinnamic acid derivatives. Four metabolites were hydroxyphenyl--302 
valerolactone derivatives, three epicatechin derivatives, two phloretin 303 
derivatives and three cyanidin derivatives.  304 
The phenolic metabolites were mainly phase-II sulphated (18), glucuronided 305 
(11) and methylated (8) conjugates formed through the action of the enzyme 306 
sulphotransferases (SULFs), uridine-5’-diphosphate glucuronosyltransferases 307 
(UGT), and catechol-O-methyltransferases (COMT), respectively. From all 308 
these phase-II metabolites, sulphation was the main transformation. The 309 
generation of simple phenolic acids, such as phenylpropionic, phenylacetic, and 310 
benzoic acid derivatives, is probably the result of microbial transformations 311 
occurring in the colon, which include ring fission, reduction, -oxidation (one 312 
decarboxylation), -oxidation (two decarboxylations), dehydroxylation and 313 
demethylation. In addition, phase-I metabolism (dehydrogenation or reduction) 314 
may also be involved in the formation of these metabolites. These simple 315 
phenolic acids can then undergo phase-II metabolism at the colon level and/or 316 
be absorbed and reach the liver, where they would be subject to enzymatic 317 
metabolism before re-entering the systemic blood circulation and finally being 318 
excreted in the urine.  319 
 320 
3.3. Proposed metabolic pathways of red-fleshed apple phenols 321 
 Based on the diversity of phenolic metabolites, whose concentration in 322 
plasma or urine increased after the apple snack intake (Table 1), a complex 323 
picture of the metabolic pathways of the main apple phenolic compounds, as 324 
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well as their interactions, has been proposed. Figure 1 shows the proposed 325 
metabolic routes to explain the phenolic metabolites generated from chlorogenic 326 
acid (in green), vanillic acid hexoside (in blue), cyanidin-3-O-galactoside (in 327 
orange), epicatechin and dimer B2 (in lilac), quercetin derivatives (in pink), and 328 
phloretin (xylosyl) glucoside (in brown) determined in the red-fleshed apple 329 
snacks as the main phenolics. The name of the phase-II enzymes is shown in 330 
green, and the colonic catabolism in brown. In the next subsections, the 331 
metabolic pathways of the metabolites generated from the apple (poly)phenols 332 
are described. 333 
 334 
3.3.1. Anthocyanins 335 
Cyanidin-3-O-galactoside, and cyanidin arabinoside (but at lower 336 
concentration levels), were the main anthocyanins present in the red-fleshed 337 
apple snack (Supporting Material Table S2). These cyanidin glycosides 338 
(galactoside and arabinoside) were also detected in both the plasma and urine 339 
samples in their native structure detected in apple snack. Other anthocyanin 340 
metabolites were also identified in the plasma and urine, derived from phase-II 341 
metabolism and microbial metabolism (Figure 1). Regarding phase-II 342 
metabolites, peonidin-3-O-galactoside was detected in the urine resulting from 343 
cyaniding-3-O-galactoside methylation by the action of COMT enzyme. 344 
Methylation, as one of the first metabolic reactions of cyanidin glycosides, was 345 
also reported by other authors in plasma and urine samples after the acute 346 
intake of aronia berry extract (Xie et al. 2016), and also after the oral ingestion 347 
of 500 mg of 13C-labelled cyanidin glucoside (De Ferrars et al. 2014).  348 
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Other cyanidin metabolites, based on the B-ring fission and cleavage of the 349 
C-ring by the action of colonic enzymes (Mosele et al. 2015), were also 350 
detected in our study. As a result, protocatechuic acid and 351 
dihydroxyphenylpropionic acid (dihydrocaffeic acid) were respectively detected. 352 
Protocatechuic acid might also have been formed by -oxidation of 353 
dihydroxyphenylpropionic acid. Then, as proposed in Figure 1 (orange arrows), 354 
protocatechuic acid could either be further degraded by the action of the 355 
microbial flora to catechol metabolites (-oxidation), pyrogallol metabolites 356 
(hydroxylation) and hydroxybenzoic acid (dehydroxylation), or methylated to 357 
vanillic acid. 358 
Despite B-ring fission and C-ring cleavage, phloroglucinol sulphate could 359 
have been generated from A-ring fission. Nevertheless, this metabolite could 360 
not be differentiated from pyrogallol sulphate due to the lack of commercially 361 
available standards and because these two metabolites have the same 362 
precursor (m/z 205) and product ions (m/z 125 and 83) (See Table 1). 363 
Therefore, this metabolite could be tentatively identified as phloroglucinol 364 
sulphate due to the A-ring fission (metabolic pathways not shown), or as 365 
pyrogallol sulphate due to hydroxylation of catechol. 366 
3.3.2. Other phenolic compounds 367 
 Chlorogenic acid (see Figure 1 green arrows). Caffeic acid would be the 368 
first metabolite generated from chlorogenic acid by ester hydrolysis (Figure 1). 369 
From this metabolite (caffeic acid), different reactions based on microbial 370 
metabolism (dehydroxylation), and phase-I (dehydrogenation or reduction) and 371 
phase-II (COMT) metabolism could occur resulting in the generation of 372 
coumaric acid, dihydroxyphenylpropionic acid and ferulic acid, respectively. 373 
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Then, dihydroxyphenylpropionic acid and ferulic acid could be further degraded 374 
to phenylpropionic acid, phenylacetic acid and vanillic acid. These metabolites 375 
could be further degraded to such simpler phenolic compounds as 376 
protocatechuic acid, p-hydroxybenzoic acid and catechol metabolites. 377 
 378 
 Vanillic acid hexoside (see Figure 1 blue arrows). Vanillic acid hexoside 379 
was the second most abundant phenolic acid quantified in the red-fleshed apple 380 
snack (Supporting Material Table S2). After deglycosylation of this phenolic 381 
acid, vanillic acid could be formed and subsequently sulphated (vanillic acid 382 
sulphate), glucuronided (vanillic acid glucuronide) and demethylated 383 
(protocatechuic acid). Then, as has been commented before, protocatechuic 384 
acid could also be further degraded by microbial activity to generate catechol 385 
and pyrogallol metabolites. 386 
The presence of the metabolites derived from these two phenolic acids 387 
(chlorogenic and vanillic acids) was in agreement with the results reported in 388 
the literature for the bioavailability study after the consumption of foods rich in 389 
these phenolics, such as coffee (Monteiro et al. 2007; Renouf et al 2010; 390 
Ludwig et al 2013;), cereals (Calani et al. 2014), olive oil enriched with thyme 391 
phenols (Rubió et al. 2014) and apple juice (Kahle et al. 2011). 392 
 393 
 Flavan-3-ols (epicatechin and dimer B2) (see Figure 1 lilac arrows). 394 
Flavan-3-ol metabolites included both phase-II and microbial catabolites. The 395 
first metabolic step would be the hydrolysis of the proanthocyanidin dimer to 396 
catechin and epicatechin, and these monomers were found in urine as 397 
glucuronided ((epi)catechin glucuronide), sulphated ((epi)catechin sulphate), 398 
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and further methylated (methyl (epi)catechin sulphate) conjugates. On the other 399 
hand, the flavan-3-ols monomers could also be metabolized by the gut 400 
microbiota to dihydroxyphenyl-γ-valerolactone, detected in urine samples. 401 
Similarly, other studies reported the valerolactones as specific flavan-3-ols 402 
metabolites (Aura, 2008; Hackman et al. 2008; Serra et al. 2011; Mosele et al. 403 
2015). Then, dihydroxyphenyl-γ-valerolactone could also be glucuronided, and 404 
further sulphated and also dehydroxylated and further sulphated. 405 
 406 
 Quercetin derivatives (see Figure 1 pink arrows). Quercetin 407 
galactoside/glucoside and arabinoside would firstly be deglycosylated, and then 408 
the generated aglycone (quercetin) could enter epithelial cells by passive 409 
diffusion and be absorbed. Nevertheless, in the present study, no phase-II 410 
metabolites of quercetin were identified. On the other hand, quercetin 411 
rhamnoside has been reported not to be metabolized in the small intestine and 412 
to reach the colon where this is metabolized to dihydroxyphenylpropionic acid 413 
(Arts et al. 2004; Aura, 2008; Serra et al. 2012; Mosele et al. 2015), and then 414 
progressively metabolized to generate simple phenols, such as phenylacetic 415 
and benzoic acids, down to catechol derivatives. In our study, only microbial 416 
metabolites from quercetin derivatives were observed. 417 
 418 
 Phloretin (xylosyl) glucoside (see Figure 1 brown arrows). Phloretin 419 
(xylosyl) glucoside could be firstly deglycosylated to generate phloretin. Then, 420 
this dihydrochalcone could be glucuronided by UGT enzymes and further 421 
sulphated with SULF enzymes. Regarding the literature, phloretin glucuronide 422 
was also reported in plasma and urine samples after the oral consumption of 423 
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apple cider (Marks et al. 2009) and apple fruit (Saenger et al. 2017). This 424 
compound could also be metabolized by the gut microbiota enzymes to 425 
dihydroxyphenylpropionic acid and further metabolized to generate simpler 426 
phenolic compounds, such as phenylacetic and benzoic acids down to catechol 427 
derivatives. 428 
 429 
3.4. Biomarkers for apple phenol consumption 430 
As evidenced in the metabolic pathways proposed in Figure 1, a large 431 
number of metabolites are generated from the five main phenolic groups 432 
(anthocyanins, phenolic acids, flavan-3-ols, flavonols and dihydrochalcones) 433 
present in the red-fleshed apple snack. Some of the metabolites identified in the 434 
plasma and urine samples after the snack intake are common to several 435 
phenolic groups. These compounds are mainly colonic metabolites, such as 436 
phenylpropionic, phenylacetic, and benzoic acids, and catechol derivatives. 437 
Additionally, these phenolic metabolites are common to other (poly)phenol-rich 438 
foods. That is why, more attention was paid in this study to specific phenolic 439 
compounds detected in plasma or urine that could be used as biomarkers for 440 
red-fleshed apple intake. The identification of the specific food intake 441 
biomarkers is of great importance to establish the relationship between 442 
(poly)phenols intake and health benefits in human intervention studies.  443 
 The 37 phenol metabolites detected in the urine and plasma samples after 444 
the red-fleshed apple snack intake (see Table 1, and Tables S3 and S4 in 445 
Supporting Material) could be classified into two groups according to their 446 
urine excretion (µmol) kinetic, as is shown in Figure 2. The first group would 447 
include derivatives from phenylpropionic and phenylacetic acids, benzoic acids, 448 
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catechol and pyrogallol and hydroxycinnamic acids (see Figure 2A); and the 449 
second group the derivatives from flavan-3-ols, valerolactones, 450 
dihydrochalcones, and anthocyanins (see Figure 2B). The phenolic metabolites 451 
from the first group are excreted at high concentration levels (µmol) in the 452 
different interval times (0 to 24 h). However, these phenolic compounds 453 
presented low specificity to be considered as intake biomarkers, as they were 454 
also quantified under basal conditions (before the apple intake), and only a 455 
slight but not significant increase in phenylpropionic/phenylacetic acids, benzoic 456 
acids and catechol/pyrogallol derivatives was observed after the apple intake in 457 
the urine excretion between 0 to 24 h. This fact was also observed in the 458 
plasma samples and their concentration was also only slightly enhanced after 459 
the intake of the red-fleshed apple snack (see Supporting Material Table S3). 460 
So, these compounds could be considered “endogenous” phenolic metabolites 461 
from the diet. 462 
 On the other hand, the phenolic metabolites from the second group were 463 
excreted in urine at concentration levels (µmol) and significantly increased 464 
(p<0.05) after the red-fleshed apple intake at the different interval times studied 465 
(see Figure 2B). Phenolic metabolites from this group could be considered as 466 
potential biomarkers for red-fleshed apple consumption, since they were 467 
detected at trace levels or not detected in basal conditions.  468 
 Figure 3 shows the individual profile of the urinary excretion (μmol and 469 
nmols for anthocyanins) of the potential biomarkers quantified after the red-470 
fleshed apple snack intake. These urinary biomarkers include cyanidin 471 
galactoside (A1), cyanidin arabinoside (A2) and peonidin galactoside (A3) as 472 
cyanidin derivatives (anthocyanins); phloretin glucuronide (B1), and phloretin 473 
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sulphate glucuronide (B2) as phloretin derivatives from dihydrochalcones 474 
pathways, epicatechin sulphate (C1), methyl epicatechin sulphate (C2) and 475 
epicatechin glucuronide (C3) as epicatechin derivatives, and dihydroxyphenyl--476 
valerolactone (D1), dihydroxyphenyl--valerolactone sulphate glucuronide (D2), 477 
dihydroxyphenyl--valerolactone glucuronide (D3) and hydroxyphenyl--478 
valerolactone sulphate (D4) as phenyl--valerolactone derivatives from flavan-3-479 
ols pathways.  480 
 As shown in Figure 3 and in Table S3 (Supporting Material), cyanidin (A1-481 
A3), phloretin (B1 and B2) and epicatechin (C1-C3) derivatives were excreted in 482 
the first hours after the apple intake, their maximum excretion being detected 483 
from 2 to 4 h. Then, their urinary excretion decreased until 24 h. These results 484 
are in agreement with other studies after apple consumption (DuPont et al. 485 
2002; Mennen et al. 2006; Kahle et al. 2007; Marks et al. 2009; Kristensen et al. 486 
2012; Saenger et al. 2017).  487 
 Note that the native forms of some apple anthocyanins, such as cyanidin-3-488 
O-galactoside, cyanidin arabinoside, and peonidin-3-O-galactoside and also 489 
phloretin glucuronide (a phase-II metabolite) were detected in the urine samples 490 
from all the volunteers. Additionally, cyanidin-3-O-galactoside and phloretin 491 
glucuronide were also detected in all the plasma samples. Observing the 492 
plasma kinetic profile of these metabolites, they were rapidly absorbed in the 493 
small intestine showing a maximum concentration at 2-3 h. After that, their 494 
concentration decreased significantly until 24 h (see Figure 4 and Supporting 495 
Material Table S4). 496 
 Regarding phenyl--valerolactone derivatives (Figure 3, D1-D4) from flavan-497 
3-ols metabolic pathways, their urinary excretion increased after the apple 498 
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snack intake showing a maximum excretion from 8 to 24 h. This trend indicates 499 
intense colonic microbial metabolism, which could explain that these 500 
compounds were not detected in the plasma. Nevertheless, in our previous 501 
study in which we analyzed whole blood by sampling with dried blood spot 502 
(DBS) cards from the same volunteers, hydroxyphenyl--valerolactone 503 
glucuronide was detected after 12 h (Yuste et al. 2018). These differences 504 
could indicate higher sensitivity in the detection of circulating valerolactones 505 
from the analysis of whole blood instead of plasma.  506 
From the results obtained in the present study, all the phenolic metabolites 507 
shown in Figure 3 could be proposed as urinary markers for red-fleshed apple 508 
consumption. Nevertheless, epicatechin and phenyl--valerolactone derivatives 509 
were not considered in the present study as biomarkers since these compounds 510 
are also present in other flavan-3-ol-rich foods, such as cocoa, wine and tea, 511 
which form part of a regular diet. Epicatechin phase-II metabolites, such as the 512 
sulphated, glucuronided and methylated derivatives found in the present study, 513 
as well as the microbial derived phenyl--valerolactone metabolites, are 514 
certainly good biomarkers for the correct assessment of intake and health 515 
effects exerted by flavan-3-ol-rich diets (Van der Hooft et al. 2012; Urpi-Sardá et 516 
al. 2015). However, when proposing intake biomarkers, more specific 517 
metabolites must be sought.  518 
On the one hand, as reported in previous studies (Mennen et al., 2006; 519 
Saenger et al., 2017) we corroborate that phloretin derived metabolites, in this 520 
study phloretin glucuronide as a phase-II metabolite was determined, are good 521 
biomarkers for apple intake, as phloretin glucoside is an exclusively apple 522 
dihydrochalcone (Richling, 2012). Moreover, phloretin glucuronide was 523 
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considered to be a good biomarkers as it was detected in all the plasma and 524 
urine samples from all the volunteers and was not detected under basal 525 
conditions. 526 
On the other hand, cyanidin-3-O-galactoside, was considered also a 527 
good intake biomarker as it is the main anthocyanin of red-fleshed apples (Guo 528 
et al., 2016; Bars-Cortina et al., 2017), and apart from these apple varieties, it 529 
can be only found in considerable amounts in chokeberry and lingonberry fruits. 530 
Therefore, cyanidin-3-O-galactoside could be considered as good intake 531 
biomarker for red-fleshed apple, and probably also for apples with white flesh 532 
and red skin, although no data where found in the literature. This metabolite 533 
was also detected in all the plasma and urine samples from all the volunteers 534 
and was not detected under basal conditions. Peonidin-3-O-galactoside was 535 
also quantified in the urine samples from all the volunteers, but at lower 536 
amounts than cyanidin-3-O-galactoside. This methyl conjugate of cyanidin-3-O-537 
galactoside (peonidin-3-O-galactoside) could also be selected as a good urinary 538 
biomarker for red-fleshed apple consumption jointly with phloretin glucuronide 539 
and cyanidin-3-O-galactoside (Figure 4).  540 
As pointed out, these three phenolic metabolites (phloretin glucuronide, 541 
cyanidin-3-O-galactoside and peonidin-3-O-galactoside) are good intake 542 
biomarkers although not strictly specific for red-fleshed apples. However, the 543 
presence of both phloretin glucuronide and cyanidin galactoside metabolites 544 
(cyanidin-3-O-galactoside and peonidin-3-O-galactoside) could be considered 545 
as more specific intake biomarkers from apples with red-flesh.  546 
Further, it is important to remark, as we previously reported (Bars-Cortina 547 
et al., 2017), that the red-fleshed apples contains a higher concentration of 548 
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anthocyanins but a lower concentration of flavan-3-ols in its flesh in comparison 549 
to the traditional white-fleshed varieties with red skin. This fact could be 550 
explained by a competitive synthesis between anthocyanins and 551 
proanthocyanidins in the flesh. Presumably this different ratio of 552 
anthocyanins/flavan-3-ols reported in red-flesh apples, might be reflected in the 553 
concentrations of the generated metabolites. So, in quantitative terms, after a 554 
red-fleshed apples intake a lower amount of flavan-3-ols metabolites would be 555 
expected in comparison to white-fleshed apples with red skin intake. To support 556 
this hypothesis, the generated metabolites after an intake of red-fleshed and 557 
traditional white-fleshed snack apples are being analyzed in an ongoing study.  558 
 559 
 560 
Conclusions 561 
 In the present study, the different phenolic metabolites generated after the 562 
intake of red-fleshed apple snacks were identified and tentatively quantified in 563 
urine and plasma samples at different time intervals. Moreover, the metabolic 564 
pathways of the phenolic metabolites generated from red-fleshed apple 565 
phenolics were proposed, and these routes were based on phase-II and 566 
microbial reactions. The results show that after the consumption of red-fleshed 567 
apple snacks, (poly)phenols are extensively metabolized, resulting in the 568 
production of a large number of compounds with different structure, all of which 569 
should be considered when investigating the potential health effects of red-570 
fleshed apples. Among all the metabolites generated, phloretin glucuronide, 571 
cyanidin-3-O-galactoside and peonidin-3-O-galactoside were proposed as the 572 
best candidates as biomarkers after the intake of red-fleshed apple snack. 573 
These two phenolic metabolites were not detected in basal samples and were 574 
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detected in the urine and/or plasma samples from all the volunteers. It is 575 
important to highlight that these three phenolic metabolites are not strictly 576 
exclusive to red-fleshed apple intake, since phloretin glucuronide is a common 577 
biomarker for all apple fruits, and cyanidin-3-O-galactoside and peonidin-3-O-578 
galactoside could appear not only after the intake of red-flesh apple but also 579 
after white-flesh with red-skin apples or other fruits such as chokeberry and 580 
lingonberry. However, the presence of these three metabolites could be useful 581 
as intake biomarkers in human intervention studies when studying the 582 
bioactivity of red-fleshed apple. 583 
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 794 
Figure 1. Proposed metabolic pathways for the generation of phenolic 795 
metabolites after the acute intake of red-fleshed apple snack. The metabolic 796 
route for chlorogenic acid is in green, for vanillic acid hexoside in blue, for 797 
anthocyanins in orange, from flavan-3-ols in lilac, from quercetin derivatives in 798 
pink and from dihydrochalcones in brown. 799 
Reactions: dH, dehydrogenation; SULT, sulphotransferase; UGT, glucuronosyl-800 
transferase; and COMT, catechol-O-methyltransferase; dOH, dehydroxylation; 801 
dMe, demethylation; -oxidation, one decarboxylation; and -oxidation, two 802 
decarboxylations.  803 
Quercetin derivatives: quercetin glucoside, quercetin galactoside, quercetin 804 
arabinoside and quercetin rhamnoside. 805 
 806 
Figure 2. Phenolic metabolite excretion rate in urine A) phenylpropionic/ 807 
phenylacetic acids, benzoic acids, catechol/pyrogallol and hydroxycinnamic 808 
acids derivatives; and B) flavan-3-ols, phenyl--valerolactones, 809 
dihydrochalcones, and anthocyanins derivatives. Except for anthocyanin 810 
derivatives (nmol/h), data expressed as μmol/h as mean values ± standard error 811 
of mean (n=10). Asterisks indicate significant differences (p0.05) in excretion 812 
rate compared to basal conditions. 813 
 814 
Figure 3.  Urinary excretion of the proposed biomarkers for red-fleshed apple 815 
consumption 0-24 h after acute intake of 80 g apple snack. A1-A3: Cyanidin 816 
derivatives; B1-B2: Phloretin derivatives; C1-C3: Epicatechin derivatives; D1-817 
D4: Phenyl--valerolactone derivatives. Except for anthocyanin derivatives 818 
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(nmol/h), data expressed as μmol/h as mean values ± standard error of mean 819 
(n=10). 820 
 821 
Figure 4. Pharmacokinetic profile of the proposed biomarkers for red-fleshed 822 
apple snack intake. In urine samples, data expressed as μmol as mean values 823 
± standard error of mean (n=10), except for anthocyanin derivatives (nmol/h).  824 
 825 
 826 
 827 
Table 1. SRM conditions used for quantification and metabolites detected in plasma and urine after acute 
intake of red-fleshed apple snack. 
 
a
Metabolites detected in urine (U) and/or plasma (P). Figures in parenthesis indicate the number of samples 
(volunteers) in which the metabolite was detected. 
 
Phenolic metabolites 
SRM 
Quantification
 
Cone voltage (V) / 
Collision energy (eV) 
Detected in
a 
     
 Catechol and pyrogallol derivatives    
1 Catechol sulphate 189  109 20 / 15 P (5), U (8) 
2 Methyl catechol sulphate 203  123 20 / 15 P (5) U (7) 
3 Methyl catechol glucuronide 299  123 40 / 15 U (6)  
4 Pyrogallol sulphate or phloroglucinol sulphate 205  125 40 / 15 P (7) U (5) 
     
 Benzoic acid derivatives    
5 Hydroxybenzoic acid 137  93 30 / 15 U (3)  
6 Hydroxybenzoic acid sulphate 217  137  35 / 15 P (3), U (3) 
7 Hydroxyhippuric acid 194  100 40 / 10 P (8) 
8 Protocatechuic acid sulphate 233  153  35 / 15 P (4), U (5) 
9 Vanillic acid sulphate 247  167 30 / 25 U (5) 
10 Vanillic acid glucuronide 343  167 30 / 25 P (9) U (3) 
     
 Phenylacetic acid derivatives    
11 Hydroxyphenylacetic acid 151  107 20 / 10 P (5), U (4) 
12 Hydroxyphenylacetic acid sulphate 231  151 20 / 15 P (6), U (4) 
13 Hydroxyphenylacetic acid glucuronide 327  151 20 / 15 U (2) 
14 Dihydroxyphenylacetic acid sulphate 247  167 30 / 15 U (5)  
15 Dihydroxyphenylacetic acid glucuronide 343  167 30 / 15 P (3), U (4) 
     
 Phenylpropionic acid derivatives    
16 Hydroxyphenylpropionic acid 165  121 20 / 10 P (4), U (6) 
17 Hydroxyphenylpropionic acid sulphate 245  165 35 / 15 U (7)  
18 Hydroxyphenylpropionic acid glucuronide 341  165 40 / 25 U (4) 
19 Dihydroxyphenylpropionic acid sulphate 261  181 40 / 15 P (2), U (5) 
20 Hydroxymethoxyphenylpropionic acid 195  136 30 / 15 P (5), U (5) 
21 Hydroxymethoxyphenylpropionic  acid sulphate 275  195 35 / 15 P (2) U (2) 
     
 Hydroxycinnamic acid derivatives    
22 Coumaric acid 163  119 35 / 10 P (2), U (5) 
23 Coumaric acid sulphate 243  163 35 / 15 U (9) 
24 Caffeic acid sulphate 259  179 35 / 15 P (2), U (2) 
25 Ferulic acid sulphate 273  193 35 / 15 P (7), U (10) 
 
  
 
 
 Phenyl--valerolactone derivatives    
26 Hydroxyphenyl--valerolactone sulphate 271  191 40 / 20 U (8) 
27 Dihydroxyphenyl--valerolactone 207  163 40 / 15 U (8) 
28 Dihydroxyphenyl--valerolactone glucuronide 383  207 40 / 20 U (8) 
29 
Dihydroxyphenyl--valerolactone sulphate 
glucuronide 
463  287 40 / 20 U (7) 
     
 Flavan-3-ol derivatives    
30 Epicatechin sulphate 369  289 40 / 20 U (6) 
31 Epicatechin glucuronide 465  289 40 / 20 U (6) 
32 Methyl epicatechin glucuronide 383  303 40 / 15 U (7) 
 
  
 
 
 Dihydrochalcone derivatives    
33 Phloretin glucuronide 449  273 40 / 20 P (10), U (10) 
34 Phloretin sulphate glucuronide 529  353 40 / 20 U (8) 
 
  
 
 
 Anthocyanin derivatives    
35 Cyanidin-3-O-galactoside 449  287 40 / 20 P (7), U (10) 
36 Cyanidin arabinoside 419  287 40 / 20 P (1). U (10) 
37 Peonidin-3-O-galactoside 463  301 40 / 20 U (10) 
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Supporting Material clean version
  Includes Supplementary Information on nutritional composition (fiber and 
macronutrients) of the red-fleshed apple snack (Table S1); concentration of the 
main phenolic compounds in red fleshed apple snack. Data are expressed as 
mg/80 g portion dry weight (mean ± SD, n=3) (Table S2); total amounts of 
phenolic compounds excreted in urine (Table S3); as well concentrations of 
phenolic compounds detected in plasma (Table S4) after red-fleshed apple snack 
intake. MS spectrum of the phenolic compounds and generated metabolites after 
the acute intake of the red-fleshed apple snack. Collision energy applied was: a) 5 
eV, b) 10 eV, c) 15 eV, d) 20 eV, and e) 25 eV (Figure S1).  
 
 MATERIAL AND METHODS 
- Nutritional facts. The samples were analysed for moisture, fat, protein, fibre 
(soluble and insoluble), sugars (reducing and non-reducing sugars) and ash 
content. All reagents used were of analytical grade. Moisture was estimated by 
weight difference after drying. Total protein content was estimated by the 
Dumas method and total fat was extracted with hexane from previously dried 
samples using a Soxhlet extractor. Insoluble fibre was determined following the 
method described by Van Soest et al. (1991), while soluble fibre was calculated 
gravimetrically as the alcohol insoluble residue according to Maran (2015). 
Sugar quantification (reducing and non-reducing sugars) was carried out by 
titrimetry based on the Fehling reaction in alkaline media after acid hydrolysis of 
non-reducing sugars. Ash content was determined by incineration at 550°C ± 
10°C.  Finally, total carbohydrates were calculated by difference. Results were 
expressed as grams of each compound per 100 grams of sample (g/100 g). 
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  Table S1. Nutritional facts of red-fleshed apple snack 
Nutritional composition Per 100g Per portion (80g) 
Calories (KJ) 
              (Kcal) 
982.6  
234.8  
786.1  
187.9 
Fat (g) 0.9  0.7  
Total Carbohydrates (g) 93.6  74.9  
- of which Sugars (g) 53.8 43.0 
Protein (g) 3.0  2.4 g 
Fibre (total) (g) 
- Soluble fibre (g) 
- Insoluble fibre (g) 
16.5  
7.6  
8.9  
13.2 
6.1 
7.1 
Minerals (g) 1.7  1.3  
 
 Table S2. Concentration of the main phenolic compounds in red fleshed apple snack. Data are 
expressed as mg/80 g portion dry weight (mean ± SD, n=3) 
Phenolic compound Concentration (mg/80 g portion) 
Anthocyanins  42.3 ± 1.18 
Cyanidin-3-O-galactoside 39.7 ± 1.03  
Cyanidin arabinoside 2.60 ± 0.24  
Phenoloc acids  88.0 ± 3.34 
Protocatechuic acid 1.71 ± 1.06  
Coumaric acid hexoside 0.77 ± 0.11   
Ferulic acid hexoside 2.12 ± 0.26  
Vanillic acid hexoside 4.28 ± 0.11  
Chlorogenic acid 79.1 ± 2.75  
Flavan-3-ols  13.8 ± 1.18 
Epicatechin 5.58 ± 0.78  
Dimer 6.92 ± 0.29  
Trimer 1.30 ± 0.12  
Flavonol  17.3 ± 1.97 
Quercetin-3-O-arabinoside 3.67 ± 0.45  
Quercetin-3-O-rhamnoside 9.26 ± 0.94  
Quercetin-3-O-glucoside 4.41 ± 0.57  
Flavanone  0.42 ± 0.02 
Eriodictyol 0.42 ± 0.02  
Dihydrochalcones  33.7 ± 3.08 
Phloretin glucoside 21.7 ± 2.54  
Phloretin xylosyl glucoside 11.7 ± 0.52  
Hydroxyphloretin xylosyl glucoside 0.32 ± 0.03  
   
TOTAL Phenols  196 ± 10.7 
 
 Table S3. Urinary excretion of phenolic compounds 0–24 h after acute intake of red-fleshed 
apple snack. Except for anthocyanin derivatives (nmol), data expressed in μmol as mean values 
± standard deviation after subtraction of baseline excretion from each volunteer. 
 
Phenolic metabolitea Basalb 0-2 h 2-4 h 4-8 h 8-24 h 
Catechol and pyrogallol derivatives       
   Catechol sulphate (n=8) 21.7 ± 3.60 2.10 ± 0.90 1.86 ± 0.80 18.2 ± 8.44 30.5 ± 4.28 
   Methyl catechol sulphate (n=7) 16.6 ± 4.80 0.82 ± 0.18 0.10 ± 0.05 1.64 ± 1.33 34.0 ± 21.9 
   Methyl catechol glucuronide (n=6) 0.27 ± 0.05 0.03 ± 0.01 0.00 ± 0.00 0.03 ± 0.02 1.09 ± 0.75 
   Pyrogallol sulphate or phloroglucinol sulphate (n=5) 1.53 ± 0.40 0.05 ± 0.03 0.15 ± 0.07 1.20 ± 0.89 1.67 ± 0.31 
      
Benzoic acid derivatives       
   Hydroxybenzoic acid (n=3) 35.3 ± 10.3 18.3 ± 12.5 16.1 ± 8.01 15.4 ± 12.3 28.9 ± 21.1 
   Hydroxybenzoic acid sulphate (n=3) 125 ± 38.1 16.2 ± 9.17 8.17 ± 3.05 2.15 ± 2.15 131 ± 121 
   Protocatechuic acid sulphate (n=5) 16.0 ± 3.74 2.85 ± 0.88 11.5 ± 2.79 4.23 ± 1.83 8.85 ± 3.88 
   Vanillic acid sulphate (n=5) 36.3 ± 7.15 3.51 ± 1.74 14.5 ± 8.71 28.9 ± 28.9 90.3 ± 52.0 
   Vanillic acid glucuronide (n=3) 2.12 ± 0.74 0.15 ± 0.11 0.53 ± 0.15 1.65 ± 1.38 2.92 ± 0.91 
      
Phenylacetic acid derivatives       
   Hydroxyphenylacetic acid (n=4) 210 ± 26.3 8.59 ± 3.87 14.5 ± 5.59 73.5 ± 34.4 93.0 ± 37.9 
   Hydroxyphenylacetic acid sulphate (n=4) 52.0 ± 6.22 11.7 ± 5.32 6.20 ± 2.14 6.34 ± 3.68 47.4 ± 27.1 
   Hydroxyphenylacetic acid glucuronide (n=2) 2.03 ± 2.03 6.92 ± 0.66 3.69 ± 1.34 2.14 ± 0.18 4.53 ± 4.53 
   Dihydroxyphenylacetic acid sulphate (n=5) 24.6 ± 4.27 3.52 ± 1.30 2.01 ± 0.89 9.07 ± 4.16 20.7 ± 5.20 
   Dihydroxyphenylacetic acid glucuronide (n=4) 4.72 ± 0.26 0.90 ± 0.43 4.77 ± 2.62 5.37 ± 4.13 5.31 ± 2.81 
      
Phenylpropionic acid derivatives       
   Hydroxyphenylpropionic acid (n=6) 2.60 ± 0.88 1.86 ± 0.90 2.65 ± 0.98 3.79 ± 1.69 11.8 ± 4.35 
   Hydroxyphenylpropionic acid sulphate (n=7) 36.6 ± 11.1 4.35 ± 0.96 2.34 ± 0.52 13.4 ± 5.67 94.8 ± 42.2 
   Hydroxyphenylpropionic acid glucuronide (n=4) 1.57 ± 0.70 0.62 ± 0.41 0.13 ± 0.06 0.22 ± 0.06 3.40 ± 0.77 
   Dihydroxyphenylpropionic acid sulphate (n=5) 21.6 ± 2.83 2.86 ± 2.08 3.26 ± 1.61 22.4 ± 11.9 12.1 ± 3.75 
   Hydroxymethoxyphenylpropionic acid (n=5) 0.15 ± 0.04 0.02 ± 0.01 0.09 ± 0.04 0.29 ± 0.13 0.58 ± 0.22 
   Hydroxymethoxyphenylpropionic acid sulphate (n=2) 0.41 ± 0.16 0.09 ± 0.04 0.09 ± 0.01 0.48 ± 0.12 0.95 ± 0.42 
      
Hydroxycinnamic acid derivatives       
   Coumaric acid (n=5) 0.07 ± 0.05 0.32 ± 0.08 0.64 ± 0.12 1.28 ± 0.30 1.84 ± 0.43 
   Coumaric acid sulphate (n=9) 0.77 ± 0.26 0.49 ± 0.10 0.80 ± 0.17 1.48 ± 0.32 2.97 ± 0.63 
   Caffeic acid sulphate (n=2) 1.31 ± 0.91 0.51 ± 0.32 1.00 ± 0.74 1.30 ± 1.15 2.01 ± 0.92 
   Ferulic acid sulphate (n=10) 1.43 ± 0.41 0.29 ± 0.08 0.59 ± 0.11 0.74 ± 0.27 0.64 ± 0.24 
      
Phenyl--valerolactone derivatives       
   Hydroxylphenyl--valerolactone sulphate (n=8) 0.15 ± 0.15 0.02 ± 0.01 0.04 ± 0.02 1.21 ± 0.97 20.7 ± 17.1 
   Dihydroxylphenyl--valerolactone (n=8) 3.51 ± 2.25 0.98 ± 0.63 2.96 ± 1.91 15.9 ± 4.61 81.9 ± 32.0 
   Dihydroxylphenyl--valerolactone glucuronide (n=8) 0.01 ± 0.01 0.00 ± 0.00 0.01 ± 0.01 0.17 ± 0.07 1.12 ± 0.73 
   Dihydroxylphenyl--valerolactone sulphate glucuronide (n=7) 0.07 ± 0.07 0.06 ± 0.03 0.16 ± 0.08 1.34 ± 0.47 9.47 ± 5.97 
      
Flavan-3-ol derivatives       
   Epicatechin sulphate (n=6) 0.14 ± 0.14 0.40 ± 0.10 0.71 ± 0.11 0.52 ± 0.13 0.49 ± 0.06 
   Epicatechin glucuronide (n=6) n.d. 0.24 ± 0.07 0.37 ± 0.06 0.51 ± 0.28 0.32 ± 0.12 
   Methyl epicatechin glucuronide (n=7) 0.07 ± 0.07 0.23 ± 0.07 0.42 ± 0.08 0.36 ± 0.11 0.17 ± 0.06 
      
Dihydrochalcone derivatives       
   Phloretin glucuronide (n=10) n.d. 0.71 ± 0.10 1.26 ± 0.32 1.06 ± 0.25 0.15 ± 0.11 
   Phloretin sulphate glucuronide (n=8) 0.03 ± 0.01 0.12 ± 0.03 0.11 ± 0.03 0.09 ± 0.02 0.13 ± 0.04 
      
Anthocyanin derivatives       
   Cyanidin-3-O-galactoside (n=10) n.d. 2.49 ± 0.42 3.46 ± 0.63 2.88 ± 0.53 2.24 ± 1.38 
   Cyanidin arabinoside (n=10) 0.45 ± 0.07 0.74 ± 0.16 0.35 ± 0.11 0.35 ± 0.13 0.00 ± 0.00 
   Peonidin-3-O-galactoside (n=10) n.d. 0.82 ± 0.15 1.61 ± 0.25 1.22 ± 0.29 0.35 ± 0.17 
 
 
a 
Figures in parenthesis next to compound names indicate the number of samples (volunteers) in which the metabolite was detected. 
b 
Content of urine collected for 12 h prior to supplementation and on an excretion per hour basis used to subtract from excretion values obtained 
after red-fleshed apple snack consumption to obtain the values cited in the Table. 
n.d.: not detected 
 
 
Table S4. Phenolic compounds concentrations in plasma 0–24 h after acute intake of red-fleshed apple snack. Data expressed in nmol/L as mean values ± 
standard deviation 
 
Phenolic compound
 a 
Basal (0 h) 0.5 h 1 h 2 h 4 h 6 h 24 h 
        
Catechol and pyrogallol derivatives        
Catechol sulphate (n=5) 310 ± 59.2 367 ± 77.7 329 ± 62.2 389 ± 84.7 743 ± 243 1220 ± 434 373 ± 70.8 
Methyl catechol sulphate (n=5) 133 ± 67.6 167 ± 79.3 195 ± 1075 159 ± 93.0 151 ± 64.5 260 ± 124 243 ± 71.3 
Pyrogallol sulphate (n=7) 17.4 ±6.19 11.8 ± 4.84 11.6 ± 5.12 11.5 ± 5.26 17.1 ± 8.28 67.6 ± 21.0 16.3 ± 5.67 
        
Benzoic acid derivative        
Hydroxybenzoic acid sulphate (n=3) 133 ± 44.1 179 ± 37.0 212 ± 52.4 132 ± 20.1 110 ± 21.3 144 ± 38.3 146 ± 52.5 
Hydroxyhippuric acid (n=8) 13.5 ± 3.50 15.9 ± 5.68 21.3 ± 5.83 26.7 ± 7.57 27.8 ± 4.84 29.4 ± 7.33 15.8 ± 7.00 
Protocatechuic acid sulphate (n=4) n.d. 19.5 ± 11.5 39.3 ± 3.15 29.2 ± 4.46 20.3 ± 10.7 16.4 ± 16.4 n.d. 
Vanillic acid glucuronide (n=9) 6.18 ± 2.52 10.7 ± 3.10 16.1 ± 2.61 23.6 ± 4.17 27.3 ± 3.25 23.9 ± 3.41 10.1 ± 2.54 
        
Phenylacetic acid derivatives        
Hydroxyphenylacetic acid (n=5) 2178 ± 148 1946 ± 131 2049 ± 133 2577 ± 262 2788 ± 137 2993 ± 195 1820 ± 157 
Hydroxyphenylacetic acid sulphate (n=6) 1016 ± 711 2047 ± 1120 2169 ± 1310 1398 ± 857 1607 ± 1166 1946 ± 1453 1523 ± 918 
Dihydroxyphenylacetic acid glucuronide (n=3) 13.0 ± 13.0 23.3 ± 23.3 39.1 ± 20.3 63.2 ± 44.5 86.1 ± 17.6 84.6 ± 31.3 13.2 ± 13.2 
        
Phenylpropionic acid derivatives        
Hydroxyphenylpropionic acid (n=4) 48.3 ± 48.3 55.4 ± 55.4 69.8 ± 69.8 265 ± 134 357 ± 186 897 ± 393 852 ± 432 
Dihydroxyphenylpropionic acid sulphate (n=2) n.d. 8.52 ± 0.95 9.94 ± 1.10 18.3 ± 2.04 38.1 ± 4.23 30.4 ± 3.37 10.4 ± 1.16 
Hydroxymethoxyphenylpropionic acid (n=5) 11.1 ± 3.58 12.9 ± 2.71 12.8 ± 2.17 25.5 ± 9.89 41.6 ± 8.77 40.5 ± 8.01 37.9 ± 17.3 
Hydroxymethoxyphenylpropionic acid sulphate (n=2) n.d. 1.26 ± 1.26 0.99 ± 0.99 6.67 ± 0.98 11.2 ± 1.07 3.20 ± 3.20 2.87 ± 2.87 
        
Hydroxycinnamic acid derivatives        
Coumaric acid (n=2) 143 ± 10.8 148 ± 24.8 171 ± 0.47 194 ± 24.2 165 ± 18.6 292 ± 30.5 157 ± 16.4 
Caffeic acid sulphate (n=2) 8.21 ± 1.99 29.1 ± 14.3 37.5 ± 13.8 14.3 ± 8.06 11.8 ± 4.59 18.7 ± 4.78 13.0 ± 1.05 
Ferulic acid sulphate (n=7) 18.2 ± 4.57 25.9 ± 4.76 25.9 ± 3.64 20.6 ± 3.09 24.8 ± 6.01 30.0 ± 3.45 17.7 ± 2.82 
        
Dihydrochalcone derivatives        
Phloretin sulphate (n=2) n.d. 20.7 ± 16.3 18.4 ± 12.4 8.35 ± 5.01 8.43 ± 5.00 24.0 ± 4.18 10.9 ± 6.81 
Phloretin glucuronide (n=10) n.d. 28.1 ± 3.54 46.7 ± 1.57 61.0 ± 6.82 53.9 ± 11.0 34.5 ± 11.7 1.16 ± 1.16 
        
Anthocyanin derivatives        
Cyanidin-3-O-galactoside (n=7) n.d. 9.66 ± 2.26 9.15 ± 1.81 10.3 ± 1.50 6.86 ± 0.74 1.52 ± 0.82 0.30 ± 0.30 
Cyanidin arabinoside (n=1) n.d. 2.60 n.d. n.d. n.d. n.d. n.d. 
 
a
Figures in parenthesis next to compound names indicate the number of samples (volunteers) in which the metabolite was detected. 
n.d.: not detected 
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